Innate Pharma SA Equity And Liabilities
Innate Pharma SA (IPHYF) had Equity And Liabilities of EUR 62.72 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-04-01
- 2025-12-31: Equity And Liabilities 62.72M EUR.
- 2025-06-30: Equity And Liabilities 92.94M EUR.
- 2024-12-31: Equity And Liabilities 111.06M EUR.
- 2024-06-30: Equity And Liabilities 151.50M EUR.
| Period end | Equity And Liabilities | Equity And Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 62.72M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 92.94M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 111.06M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 151.50M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 175.19M EUR 20-F · filed 2026-04-01 | 184.19M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 199.05M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 199.29M EUR 20-F · filed 2025-04-30 | 207.86M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 280.43M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 267.50M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 266.22M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 307.42M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 401.36M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 451.22M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 255.02M EUR 20-F · filed 2020-04-24 |